Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012
Oversights in the design and conduct of phase I trials have resulted in morbidity and mortality1,2. Empirical evidence to improve regulatory review of phase I trials is lacking. We studied the characteristics of phase I trials, frequency of harms, and dissemination of results.
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Medical Association
2017
|
| _version_ | 1797090773775155200 |
|---|---|
| author | Odutayo, A Copsey, B Dutton, S Cook, J Hopewell, S Altman, D |
| author_facet | Odutayo, A Copsey, B Dutton, S Cook, J Hopewell, S Altman, D |
| author_sort | Odutayo, A |
| collection | OXFORD |
| description | Oversights in the design and conduct of phase I trials have resulted in morbidity and mortality1,2. Empirical evidence to improve regulatory review of phase I trials is lacking. We studied the characteristics of phase I trials, frequency of harms, and dissemination of results. |
| first_indexed | 2024-03-07T03:23:32Z |
| format | Journal article |
| id | oxford-uuid:b840a81a-6112-40ef-8029-d3f2205a9cca |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:23:32Z |
| publishDate | 2017 |
| publisher | American Medical Association |
| record_format | dspace |
| spelling | oxford-uuid:b840a81a-6112-40ef-8029-d3f2205a9cca2022-03-27T04:54:36ZCharacteristics and dissemination of phase I trials approved by a UK Regional Office in 2012Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b840a81a-6112-40ef-8029-d3f2205a9ccaSymplectic Elements at OxfordAmerican Medical Association2017Odutayo, ACopsey, BDutton, SCook, JHopewell, SAltman, DOversights in the design and conduct of phase I trials have resulted in morbidity and mortality1,2. Empirical evidence to improve regulatory review of phase I trials is lacking. We studied the characteristics of phase I trials, frequency of harms, and dissemination of results. |
| spellingShingle | Odutayo, A Copsey, B Dutton, S Cook, J Hopewell, S Altman, D Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title | Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title_full | Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title_fullStr | Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title_full_unstemmed | Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title_short | Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012 |
| title_sort | characteristics and dissemination of phase i trials approved by a uk regional office in 2012 |
| work_keys_str_mv | AT odutayoa characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 AT copseyb characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 AT duttons characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 AT cookj characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 AT hopewells characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 AT altmand characteristicsanddisseminationofphaseitrialsapprovedbyaukregionalofficein2012 |